Acurx Pharmaceuticals

Acurx Pharmaceuticals is a publicly held, clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention, and Food and Drug Administration.

Phase 2b Clinical Study in C. difficile Infection currently enrolling

Learn More